,,iv #aai? ,,congress #a/ ,session ,h4 ,,res4 #bde ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,m>* #bd1 #bjbe,mr4 ,morelle submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,recogniz+ ! significance ( ,sjgr5's disease z a s]i\s & sy/emic autoimmune disease & express+ support = ! designation ( ,april #bjbe z ,sjgr5's ,aw>5ess ,mon?4 ,:]eas up to #d1jjj1jjj adults 9 ! ,unit$ ,/ates are liv+ ) ,sjgr5's disease 7,sjgr5's72 ,:]eas ,sjgr5's is a sy/emic autoimmune disease t affects ! entire body2 ,:]eas ! *>act]i/ic symptoms ( ,sjgr5's include pr(\nd fatigue1 ext5sive dryness ?r\gh\t ! body 7includ+ ! eyes1 m\?1 esophagus1 s9uses1 sk91 & g5itals71 & pa92 ,:]eas complications f ,sjgr5's include *ronic pa91 major organ involvem5t1 neuropa?ies1 cognitive dysfunction1 ga/ro9te/9al dysfunction1 int]/itial cy/itis1 lymphomas1 &1 9 babies ^: mo!rs h ,sjgr5's1 fetal he>tblock 2 ,:]eas ! av]age age = a diagnosis ( ,sjgr5's is curr5tly betwe5 ! ages ( #de & #ee1 al?\gh ,sjgr5's c affect individuals ( all ages2 ,:]eas ! ratio ( wom5 to m5 liv+ ) a ,sjgr5's diagnosis is approximately #i to #a2 ,:]eas ! cause ( ,sjgr5's is n kn[n1 & !re is no s+le te/ to diagnose ! autoimmune disease2 ,:]eas individuals liv+ ) ,sjgr5's mu/ be> high out-(-pocket co/s 9 ord] to af=d m$ications to control inflammation & dryness1 relieve jo9t1 muscle1 & n]ve pa91 r$uce acid reflux due to limit$ saliva production1 & treat ! deva/at+ complications ( oral1 ocul>1 & o!r dryness2 ,:]eas rheumatologi/s prim>ily treat individuals ) ,sjgr5's1 b a wide v>iety ( o!r speciali/s are also involv$ ) ! treatm5t ( ,sjgr5's1 includ+ d5ti/s1 neurologi/s1 ocul> speciali/s1 otol>yngologi/s1 ga/ro5t]ologi/s1 nephrologi/s1 & pulmonologi/s2 ,:]eas ,sjgr5's is (t5 difficult to diagnose &1 s9ce _m heal? c>e provid]s are unfamili> ) ! disease1 additional tra9+ is ess5tial to ensure pati5ts receive accurate & timely diagnoses2 ,:]eas ! physical & psy*ological impact ( ,sjgr5's c sev]ely affect an individual's duties at home & 9 ! workplace2 ,:]eas !re is a ne$ to update ! nom5clature to classify ,sjgr5's z a disease1 includ+ by ! ,f$]al ,gov]nm5t2 ,:]eas !re is a ne$ = m rese>* to und]/& ! pa?ology t leads to ! autoimmune attack 9 ,sjgr5's1 includ+ ! role ( ! int]play ( ! immune & n]v\s sy/ems2 ,:]eas cl9ical trials are und]way to te/ ! efficacy ( t>get$ !rapies t w address ! cause ( ,sjgr5's1 & rese>* is und]way to id5tify g5es & environm5tal influ5ces t may contribute to und]/&+ :o is susceptible to ,sjgr5's2 & ,:]eas m rese>* is ne$$ to id5tify new !rapies & cle> biom>k]s to help individuals ) ,sjgr5's manage ! symptoms & complications z !y age3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 recognizes ,sjgr5's disease z a s]i\s heal? issue t causes a significant heal? burd52 7#b7 enc\rages ! ,secret>y ( ,heal? & ,human ,s]vices & ! heads ( o!r relevant ag5cies-- 7,a7 to exp&1 enhance1 & increase rese>* ( ,sjgr5's disease & id5tify new areas ( rese>* ?r\gh ! ,(fice ( ,autoimmune ,disease ,rese>*2 7,b7 to improve ! und]/&+ ( ! causes ( ,sjgr5's disease & id5tify biom>k]s t w help ) pati5t /ratification & diagnosis1 disease managem5t1 & developm5t ( t>get$ !rapies = ,sjgr5's pati5ts2 7,c7 to bett] quantify & regul>ly track ! numb] ( ,sjgr5's pati5ts1 z _m individuals are believ$ to be undiagnos$ or are misdiagnos$1 su* z ^? t h ,sjgr5's disease & ano!r autoimmune disease2 7,d7 to update lit]ature on ,sjgr5's disease & dissem9ate su* lit]ature to heal? provid]s to increase aw>5ess & accurate k ab\t ! disease2 & 7,e7 to build aw>5ess ( ,sjgr5's disease among physicians & communities 9 und]s]v$ areas s t pati5ts ) ,sjgr5's disease are diagnos$ correctly & obta9 ! c>e !y ne$2 & 7#c7 expresses support = ! designation ( ,sjgr5's ,aw>5ess ,mon?4